4DMedical jumps after deploying lung imaging technology in the US
Make us a preferred source
Make us a preferred source on Google
More news: Shares in 4DMedical have skyrocketed in morning trade after the company has deployed its imaging technology CT:VQ at Mayo Clinic in the US.
Shares were up 34.34%, to $6.22, at 11:55am AEDT.
4DMedical confirms ‘uniquely significant’ deployment at Mayo Clinic
The news: Medtech company 4DMedical has announced deployment of its flagship lung imaging technology CT:VQ at Mayo Clinic in the US.
The context: Under the arrangement, Mayo Clinic will use CT:VQ for ventilation and perfusion analysis and assess its application across a range of clinical use cases.
Mayo Clinic is now the sixth US academic medical centre (AMC) to adopt CT:VQ since receiving regulatory approval by the Food and Drug Administration last year.
Melbourne-based 4DMedical said the clinic’s deployment represents “one of the most significant institutional endorsements to date” and reinforces CT:VQ’s reputation among the elite healthcare institutions in the US.
The 90-day agreement is not financially material, the company noted.
What they said: “Mayo Clinic is, unquestionably, one of the most respected healthcare institutions in the world,” said 4DMedical CEO and founder Andreas Fouras.
“Their decision to deploy CT:VQ is a landmark moment for 4DMedical and a powerful testament to the clinical significance of our technology,” Fouras said.
“Mayo’s deployment is uniquely significant. When the world’s number one hospital chooses to use your technology, it sends the strongest possible signal to the entire US healthcare market about the clinical value and readiness of CT:VQ.”
The source: ASX
